Loading…
← CockpitCompetitor Analysis › GALAXYSURF.NS Galaxy Surfactants Ltd.Open in the cockpit ↗

Galaxy Surfactants Ltd.GALAXYSURF.NSCompetitor analysis, valuation and peers

India · INR·FMCG›Household/Personal Care
Momentum neutral 54
Mkt cap
$845M
US dollars, full cap
Free float
27%
of shares outstanding
$/day
$812,723
20-day average traded
Fwd P/E
17.6×
forward earnings
ROIC−WACC
+1.8 pp
WACC 14.4%
Hurdle
+5 pp
Req g minus delivered
Next earnings
82 days
8 Feb 2027
Close · INR₹2,217
1D+0.3%
1W0.0%
1M-9.1%
3M-9.1%
6M+22.2%
YTD+8.2%
1Y-1.2%
ATR %3.6%
Beta0.87
52w lowhigh17.8% off high

What Galaxy Surfactants does

Employees: 1,522

Galaxy Surfactants at a glance

Size Galaxy Surfactants (GALAXYSURF.NS) is an India Consumer Staples company (Household/Personal Care) with a market value of $845M, the 656th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹2,217 on 18 Nov 2026.

Performance Over six months the shares gained 22.2%, against +4.3% for the median peer and +3.8% for the India market (cap-weighted) — 6th highest of 21 in its peer set.

Growth Revenue grew 30.2% over the last twelve months (peer median +10.2%); the operating margin is 8.7% (peer median 9.9%).

Valuation It trades at 17.6× forward earnings against a peer median of 18.9× (8th cheapest of 20).

Price implies For today's price to make sense, revenue must grow about 19% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is +5 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 1.8 points above its cost of capital (14.4% WACC).

Next results Next results expected around 8 Feb 2027 (exchange calendar; dates can move).

Relative performance

8010012014021 May 202621 Aug 202618 Nov 2026GALAXYSURF.NS 121Peer median 107
Six months, rebased to 100: Galaxy Surfactants against the median of its 20 peers (local-currency closes).

Galaxy Surfactants financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹62.4B₹52.3B₹42.0B₹37.7B₹44.3B
Revenue growth—+24%+12%-15%—
Gross profit₹11.9B₹7.55B₹8.03B₹7.15B₹9.03B
EBITDA₹6.80B₹4.62B₹4.70B₹4.42B₹5.42B
Net income₹4.07B₹2.67B₹3.05B₹3.01B₹3.81B
Free cash flown/a₹1.85B₹2.01B₹3.51B₹4.06B
Capital expendituren/a₹1.37B₹2.19B₹1.58B₹1.46B
Total debt₹2.95B₹2.35B₹2.10B₹1.87B₹3.27B

Quarterly statements and history in the cockpit →

Galaxy Surfactants competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%+50%-20%0%241710300740001328603193301108JYOTHYLAB4919492860500926574836502145BAJAJCONEPC003006PZCICOS301371002790GALAXYSURF.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Galaxy Surfactants is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%+80%20×40×241710300740001328603193301108JYOTHYLAB4919492860500926574836502145BAJAJCONEPC003006PZC301371002790GALAXYSURF.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Galaxy Surfactants is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%300740001328603193301108JYOTHYLAB4919492826574836502145BAJAJCON003006PZC301371002790GALAXYSURF.NSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Galaxy Surfactants is the large dot.

Galaxy Surfactants competitors and peer comparison

How Galaxy Surfactants compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Galaxy Surfactants against its 20 peers (data as of 18 Nov 2026)
MeasureGALAXYSURF.NSPeer medianRank in peer set
1-month return-9.1%-2.1%8th lowest of 21
6-month return+22.2%+4.3%6th highest of 21
Distance from 52-week high-17.8%-33.6%7th highest of 21
Revenue growth (TTM)+30.2%+10.2%4th highest of 21
Operating margin8.7%9.9%10th lowest of 21
Forward P/E17.6×18.9×8th cheapest of 20
Growth the price implies (Req g, 7 yrs)18.5%4.3%4th most demanding of 18
Growth delivered (Del g)+13.7%+8.2%6th highest of 18
Hurdle (Req g minus delivered)+4.8 pp-4.4 pp6th most demanding of 18
ROIC minus cost of capital+1.8 pp+7.1 pp8th lowest of 21
EV / EBITDA10.9×9.6×4th most expensive of 13
Net debt / EBITDA-0.7×-1.1×6th most indebted of 13

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Galaxy Surfactants GALAXYSURF.NSIndia$845M+22%+30%9%17.6×18.5%+13.7%
Cosmecca Korea 241710.KSSouth Korea$847M+23%+42%12%16.3×n/an/a
SYoung 300740.SZChina$816M-48%+14%3%33.4×14.0%+6.1%
Dencare (Chongqing) Oral Care 001328.SZChina$912M+13%+10%11%27.9×3.7%+10.8%
Runben Biotechnology 603193.SSChina$918M-30%+13%21%18.5×1.5%+28.4%
Tongling Jieya Biologic Technology 301108.SZChina$933M+56%+24%5%52.5×28.5%+0.8%
Jyothy Labs JYOTHYLAB.NSIndia$762M-9%+5%8%40.8×34.5%+8.9%
Milbon 4919.TJapan$743M+48%+8%14%25.7×-3.3%+8.2%
Noevir 4928.TJapan$978M+7%-3%28%20.4×-12.8%+4.1%
Hangzhou Haoyue Personal Care 605009.SSChina$726M-18%+10%6%17.7×4.4%+7.7%
Shanghai Forest Cabin Cosmetics 2657.HKHong Kong$1.04B+15%+74%18%11.8×11.3%+49.0%
d'Alba Global 483650.KSSouth Korea$1.13B-55%+49%22%12.0×-6.6%+53.0%
Shanghai Chicmax Cosmetics 2145.HKHong Kong$1.17B-42%+23%8%14.4×-6.1%+21.2%
Bajaj Consumer Care BAJAJCON.NSIndia$560M-24%+29%22%19.7×14.8%+5.0%
Edgewell Personal Care EPCUnited States$1.30B+67%-10%7%14.2×n/an/a
Chongqing Baiya Sanitary Products 003006.SZChina$1.35B+27%0%3%37.3×28.8%+22.8%
PZ Cussons PZC.LUnited Kingdom$527M+13%+5%11%12.7×-2.3%-2.1%
Intercos ICOS.MIItaly$1.43B+12%-5%9%18.9×4.3%+11.5%
Harbin Fuerjia Technology 301371.SZChina$1.51B-39%+28%20%21.4×7.5%+3.6%
Qingdao Kingking Applied Chemistry 002094.SZChina$454M-26%+3%4%n/an/an/a
AMOREPACIFIC 002790.KSSouth Korea$1.61B+2%+9%9%8.5×-5.7%-1.3%

Questions

Which companies are Galaxy Surfactants's closest peers?
The cockpit's peer set: Cosmecca Korea (241710.KS), SYoung (300740.SZ), Dencare (Chongqing) Oral Care (001328.SZ), Runben Biotechnology (603193.SS), Tongling Jieya Biologic Technology (301108.SZ), Jyothy Labs (JYOTHYLAB.NS), Milbon (4919.T), Noevir (4928.T).
Is Galaxy Surfactants expensive compared with its peers?
On forward p/e it trades at 17.6× against a peer median of 18.9×, 8th cheapest of 20 in its peer set. For today's price to make sense, revenue must grow about 19% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is +5 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Galaxy Surfactants stock performed?
Over six months to 18 Nov 2026 the shares returned +22.2% against +4.3% for the median peer; over one year -1.2%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.